» Articles » PMID: 37787243

Commentary on 'Optical Coherence Tomography Angiography Parameters in Patients Taking Hydroxychloroquine Therapy - Cross-sectional Study'

Overview
Specialty Ophthalmology
Date 2023 Oct 3
PMID 37787243
Authors
Affiliations
Soon will be listed here.
References
1.
Bulut M, Akidan M, Gozkaya O, Erol M, Cengiz A, Cay H . Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Graefes Arch Clin Exp Ophthalmol. 2018; 256(11):2075-2081. DOI: 10.1007/s00417-018-4117-3. View

2.
Agrawal R, Xin W, Keane P, Chhablani J, Agarwal A . Optical coherence tomography angiography: a non-invasive tool to image end-arterial system. Expert Rev Med Devices. 2016; 13(6):519-21. DOI: 10.1080/17434440.2016.1186540. View

3.
Vasilijevic J, Kovacevic I, Dijana R, Dacic B, Maric G, Stanojlovic S . Optical coherence tomography angiography parameters in patients taking hydroxychloroquine therapy. Indian J Ophthalmol. 2023; 71(10):3399-3405. PMC: 10683689. DOI: 10.4103/IJO.IJO_740_23. View

4.
Sambhav K, Grover S, Chalam K . The application of optical coherence tomography angiography in retinal diseases. Surv Ophthalmol. 2017; 62(6):838-866. DOI: 10.1016/j.survophthal.2017.05.006. View

5.
Akhlaghi M, Kianersi F, Radmehr H, Dehghani A, Beni A, Noorshargh P . Evaluation of optical coherence tomography angiography parameters in patients treated with Hydroxychloroquine. BMC Ophthalmol. 2021; 21(1):209. PMC: 8112017. DOI: 10.1186/s12886-021-01977-5. View